Stocks SPTJF Financial statements
Financial statementsSINOPEC SHANGHAI PETROCHEMICAL CO LTD financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data SINOPEC SHANGHAI PETROCHEMICAL CO LTD files with the SEC in its annual reports.
In CNY millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2015 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 80,748 | 77,843 | 91,962 | 107,689 | 100,270 | 74,624 | 89,198 | 82,443 |
| Cost of revenue | 62,757 | 58,732 | 72,398 | 89,839 | 86,468 | 61,901 | 74,298 | 76,266 |
| Gross profit | 4,280 | 7,205 | 6,820 | 5,775 | 1,588 | -340 | 1,591 | -3,611 |
| Selling, general and administrative | 601 | 546 | 535 | 536 | 550 | 486 | 368 | 289 |
| Operating income | 3,909 | 6,778 | 6,402 | 5,585 | 1,321 | -466 | 1,432 | -3,843 |
| Interest expense | 293 | 53.6 | 61 | 106 | 53.8 | 99 | 94.2 | 98.5 |
| Interest income | 49.3 | 137 | 268 | 444 | 417 | 431 | 509 | 542 |
| Pre-tax income | 4,237 | 7,778 | 7,853 | 6,808 | 2,656 | 591 | 2,721 | -3,574 |
| Income tax | 927 | 1,797 | 1,699 | 1,472 | 429 | -65.6 | 644 | -731 |
| Net income to minority interests | 36.1 | 13 | 10.9 | -0.11 | 11.4 | 11.3 | 3.18 | 3.86 |
| Net income | 3,274 | 5,968 | 6,143 | 5,336 | 2,216 | 645 | 2,073 | -2,846 |
| EBITDA | 5,954 | 8,660 | 8,236 | 7,393 | 3,159 | 1,361 | 3,398 | -2,030 |
| EPS, basic | 0.30 | 0.55 | 0.57 | 0.49 | 0.21 | 0.06 | 0.19 | -0.26 |
| EPS, diluted | 0.30 | 0.55 | 0.57 | 0.49 | 0.21 | 0.06 | 0.19 | -0.26 |
Balance sheet
| FY2015 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,077 | 5,441 | 7,504 | 8,742 | 7,450 | 6,916 | 5,112 | 889 |
| Receivables | 3,276 | 3,514 | 2,407 | 1,668 | 1,224 | 1,337 | 2,816 | |
| Inventory | 6,159 | 6,598 | 8,121 | 6,754 | 3,889 | 5,924 | 7,294 | |
| Total current assets | 14,876 | 19,866 | 25,299 | 22,309 | 17,305 | 20,932 | 15,766 | |
| Property, plant and equipment | 14,383 | 13,474 | 12,866 | 11,646 | 11,301 | 11,713 | 11,310 | 12,180 |
| Lease right-of-use assets | 0 | 344 | 411 | 386 | 380 | |||
| Total assets | 33,946 | 39,443 | 44,386 | 45,494 | 44,619 | 46,921 | 41,137 | |
| Accounts payable | 7,313 | 9,209 | 8,090 | 3,563 | 2,820 | 3,096 | 2,927 | |
| Short-term debt | 546 | 606 | 497 | 1,548 | 1,548 | 1,560 | 1,550 | |
| Total current liabilities | 8,942 | 10,922 | 13,913 | 15,480 | 15,232 | 15,796 | 13,998 | |
| Lease liabilities | 0 | 10.6 | 3.12 | 1.38 | 7.51 | |||
| Total liabilities | 8,942 | 10,928 | 13,923 | 15,500 | 15,284 | 16,543 | 14,781 | |
| Total debt | 1,548 | 2,260 | 2,250 | |||||
| Shareholders' equity | 24,722 | 28,230 | 30,346 | 29,863 | 29,198 | 30,242 | 26,228 | |
| Minority interests | 281 | 285 | 116 | 131 | 137 | 135 | 128 | |
| Total equity | 20,095 | 25,003 | 28,516 | 30,462 | 29,994 | 29,335 | 30,377 | 26,355 |
| Total liabilities and equity | 33,946 | 39,443 | 44,386 | 45,494 | 44,619 | 46,921 | 41,137 |
Cash flow statement
| FY2015 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | |
|---|---|---|---|---|---|---|---|---|
| Net income | 3,310 | 5,981 | 6,154 | 5,336 | 2,227 | 656 | 2,077 | -2,842 |
| Depreciation and amortization | 2,045 | 1,882 | 1,834 | 1,808 | 1,839 | 1,827 | 1,966 | 1,813 |
| Cash from operations | 4,933 | 7,182 | 7,061 | 6,659 | 5,058 | 1,680 | 3,950 | -7,459 |
| Capital expenditures | -1,430 | -1,841 | -3,224 | -2,837 | ||||
| Cash from investing | -439 | -190 | -2,401 | -1,928 | -4,623 | -3,888 | -2,359 | 4,390 |
| Dividends paid | -1,080 | -2,700 | -3,247 | -2,706 | -1,299 | -1,082 | -1,082 | |
| Cash from financing | -3,696 | -2,637 | -2,590 | -3,507 | -1,737 | 1,682 | -3,393 | -1,169 |
| Exchange rate effect | 0.1 | 8.48 | -6.69 | 13.8 | 10.6 | -7.4 | -1.86 | 15.3 |
| Free cash flow | 3,627 | -161 | 726 | -10,296 | ||||
| Interest paid | 34.3 | 63.4 | 71.4 | 110 | 122 | |||
| Income taxes paid | 33.1 | 1,268 | 1,706 | 1,806 | 534 | 244 | 352 | 377 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | -4.4% | Gross profit / revenue. |
| Operating margin | -4.7% | Operating income / revenue. |
| EBITDA margin | -2.5% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -4.3% | Pre-tax income / revenue. |
| Net margin | -3.5% | Net income / revenue. |
| FCF margin | -12.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -9.0% | Cash from operations / revenue. |
| Return on equity (ROE) | -10.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -6.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | -11.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 0.4% | Selling, general and administrative expense / revenue. |
| Capex / revenue | 3.4% | Capital expenditures / revenue. |
| D&A / revenue | 2.2% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -7.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -6.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -2.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -327.0% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Operating income growth, 1y | -368.3% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -159.7% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | -237.3% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -237.0% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -288.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -1,518.0% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | -13.3% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -4.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -1.5% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -12.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -3.3% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 0.8% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.13x | Current assets / current liabilities. |
| Quick ratio | 0.26x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.06x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.09x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 5.5% | Total debt / total assets. |
| Liabilities / assets | 35.9% | Total liabilities / total assets. |
| Net debt | CN¥1.36B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -39.0x | Operating income / interest expense. |
| Working capital | CN¥1.77B | Current assets - current liabilities. |
| Tangible book value | CN¥26.23B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.87x | Revenue / average total assets. |
| Fixed asset turnover | 7.02x | Revenue / average property, plant and equipment. |
| Inventory turnover | 11.5x | Cost of revenue / average inventory. |
| Days inventory | 32 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 39.7x | Revenue / average receivables. |
| Days sales outstanding | 9 days | 365 x average receivables / revenue. |
| Days payables | 14 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 26 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -CN¥0.26 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -CN¥0.26 | Net income per basic share, as reported (split-adjusted). |
What was SINOPEC SHANGHAI PETROCHEMICAL CO LTD's revenue in fiscal 2022?
SINOPEC SHANGHAI PETROCHEMICAL CO LTD reported revenue of CN¥82.44B for fiscal 2022, 7.6% lower than the year before.
Was SINOPEC SHANGHAI PETROCHEMICAL CO LTD profitable in fiscal 2022?
No. It reported a net loss of CN¥2.85B.
How much free cash flow did SINOPEC SHANGHAI PETROCHEMICAL CO LTD generate in fiscal 2022?
Cash from operations of CN¥7.46B minus capital expenditures of CN¥2.84B left free cash flow of -CN¥10.30B.